(PRGO) Perrigo - Ratings and Ratios

Perrigo Company PLC is a leading global provider of over-the-counter (OTC) health and wellness products, operating in the US, Europe, and internationally through its Consumer Self-Care Americas and Consumer Self-Care International segments. The companys diverse product portfolio includes upper respiratory, nutrition, digestive health, pain and sleep-aids, oral care, and skin care products, among others, sold under various brands such as Compeed, Good Sense, and Mederma.

The companys business model is built around providing affordable, high-quality self-care products to consumers, leveraging its strong distribution network across retail drug, supermarket, and mass merchandise chains, as well as e-commerce platforms. With a history dating back to 1887, Perrigo has established itself as a significant player in the OTC pharmaceuticals industry, with a presence in multiple geographies and a robust product portfolio.

From a technical analysis perspective, Perrigos stock price is currently at $26.17, slightly below its 20-day simple moving average (SMA) of $26.47, indicating a potential short-term bearish trend. However, the stock is above its 50-day and 200-day SMAs, suggesting a longer-term bullish trend. The average true range (ATR) of 0.65 indicates a relatively stable volatility profile.

Fundamentally, Perrigos market capitalization stands at $3.73 billion, with a forward price-to-earnings (P/E) ratio of 8.95, suggesting a relatively attractive valuation. However, the companys return on equity (ROE) is negative, indicating potential underlying issues with profitability. Despite this, the companys diverse product portfolio and global presence provide a solid foundation for potential future growth.

Based on the technical and fundamental data, a potential forecast for Perrigos stock price could be a short-term correction towards the $25.77 level (200-day SMA), followed by a potential rebound towards the $28.86 level (52-week high) if the company can demonstrate improved profitability and operational efficiency. A key catalyst to watch would be the companys ability to successfully integrate its product portfolio and expand its presence in key markets.